Verdezyne raises $3M for organism-made biofuels

Verdezyne, a company that develops special microorganisms used to produce biofuels and biochemicals, has brought in $3 million of an expected $15.2 million round of equity, according to a filing with the SEC. Based in Carlsbad, Calif., the company is backed by Life Science Angels,… Continue Reading

Satoris closes $1.1M for Alzheimer’s diagnostics

Satoris, a Redwood City, Calif. company that makes bloodstream-based diagnostic tests for Alzheimer’s disease, says it has raised $1.12 million toward an anticipated $1.5 million bridge round, which will be used to commercialize its lead product, reports VentureWire.

The plan is to market the tests to… Continue Reading

Biomimedica raises $2.4 million for joint repairs

Biomimedica has raised $2.4 million in a first round for its joint-repair business.

VentureWire reported that Emergent Medical Ventures led the round. Other investors include Asset Management Co. and Life Science Angels.

Based in Santa Clara, Calif., Biomimedica was started earlier this year. The company is developing… Continue Reading

Life-science briefing: Thursday, March 27, 2008

Life-science briefing: Thursday, March 27, 2008

TODAY’S HEADLINES:

Breathe Tech raises $15M for respiratory disease (release)
Protein-drug maker Pieris takes in €25M (release)
Apthera takes in $2.1M toward cancer vaccine (VentureWire)

Breathe Tech raises $15M for respiratory disease – Breathe Technologies, a Fremont, Calif., medical device maker, raised $15 million in a second round of funding…. Continue Reading

Satoris raises $5M, preps Alzheimer’s test for research use

Satoris raises $5M, preps Alzheimer’s test for research use

Redwood City, Calif.-based Satoris, a biotech developing a blood test for Alzheimer’s disease, raised $5 million in a second funding round, VentureWire reports. The deal values Satoris at $13.8 million after the financings. The company had previously raised $1 million from individuals, and said it… Continue Reading

Satoris seeks $5M for Alzheimer’s test — with high errors

Satoris seeks $5M for Alzheimer’s test — with high errors

Satoris, a Redwood City, Calif., biotech developing a diagnostic test for Alzheimer’s disease, is close to raising $5 million in a second funding round, VentureWire reports (subscription required). The funds will allow the company to make its test available to outside researchers.

Satoris made a big… Continue Reading

Life sciences briefing: Thursday, Nov. 15, 2007

Life sciences briefing: Thursday, Nov. 15, 2007

Featured companies: BioVex, FullTurn Media, Humanetics, N Spine, Novitas Capital, Reliant Technologies, Symbios, Vaxart, Virtual Radiologic, Winston Laboratories, Zosano Pharma

EXPANDING ITEMS: Stay tuned.

Vaxart receives $3.3M for oral vaccines — San Francisco’s Vaxart, a biotech developing novel adenovirus-based vaccines, raised $2.7 million in a first funding round. Vaxart… Continue Reading

Life sciences briefing: Tuesday, Nov. 13, 2007

Life sciences briefing: Tuesday, Nov. 13, 2007

Featured companies: Akermin, Fluxion Biosciences, iCardiacTechnologies, Wellocities

UPDATED: Expanded items on Fluxion, Akermin, and Wellocities.

Fluxion Bio draws in $6.9M for cell-analysis tools — Fluxion Biosciences, a San Francisco developer of cellular-analysis tools, raised $6.9 million in a second funding round, VentureWire reports (subscription required). Investors included Kodiak Venture… Continue Reading

Coda Genomics: Better proteins through engineering

Coda Genomics: Better proteins through engineering

Coda Genomics, a Laguna Hills, Calif., biotechnology company founded in 2005, concentrates on a thorny but little-realized challenge in biotechnology: Genetic engineering is easy. Protein manufacture is hard.

The biotech industry was founded on the science of recombinant DNA, which is essentially the trick of… Continue Reading

Secretive medical device maker, VasoNova, raises $1.25M

VasoNova , a Sunnyvale, Calif. medical device startup that is still secretive, has secured $1.25 million of a $4.7 million Series A round, according to a regulatory filing cited by PE Week. Backers include Life Science Angels, Aphelion Medical Fund and Coronis Medical Ventures.

Continue Reading